iX Biopharma secures TGA GMP licence for its testing laboratory
SINGAPORE: iX Biopharma Ltd announced that its wholly-owned subsidiary, iX Syrinx has obtained the Good Manufacturing Practice (GMP) licence issued by the Therapeutic Goods Administration (TGA) of Australia for its testing laboratory located within its facility in Victoria, Australia. As…